|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| Effect of oral contraceptives on blood coagulation and liver tests. |
| Halbrecht J; Rubinstein J; Menache R; Creter D |
| Israel Journal of Medical Sciences 9(4): 564-565. April 1973. |
| Studies on oral contraceptives, before and after treatment during different periods throughout 4 years, were carried out |
| on 40 women. The following tests were done: 1) 1st stage of coagulation: bleeding time, platelet count, platelets |
| aggregation test, platelets adhesiveness, clot retraction, and prothrombin consumption index. 2) 2nd stage of |
| coagulation: Quick's prothrombin and thrombin time. 3) 3rd stage of coagulation: fibrinogen, Factor 13 (fibrinogen- |
| stabilizing factor), euglobulin lysis time, whole blood clot-lysis time, and fibrinogen degradation products. A test |
| including all 3 stages was the kaolin-activated partial-thromboplastin time (PTT) test. Also, calcium concentration |
| and the clotting time in glass tube were determined and a thromboelastogram was made on platelet-rich plasma. |
| Blood was taken on the same day for the determination of serum proteins, bilrubin, and the activity of alkaline |
| phosphatase and glutamate pyruvate aminotransferase (GPT). The coagulation tests were within normal limits |
| during the treatment, except for the clotting time and the PTT, which were within lower limits of the normal range, |
| indicating a tendency to hypercoagulation. The platelet count was normal, but the ADP-induced adhesiveness was |
| increased. The thromboelastogram showed a shortening of r. Liver function tests were within normal limits in all |
| cases. Conclusion: The oral contraceptive treatment may induce slight hypercoagulability, a finding which is in |
| accordance with other studies on the same subject. (PubHealth.info Document ID: CONT8T 574-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "Effect of oral contraceptives on blood coagulation and liver |
| tests. (Abstract only)", is(are) Halbrecht J; Rubinstein J; Menache R; Creter D. The source of this article is "Israel |
| Journal of Medical Sciences 9(4): 564-565. April 1973.". This article was published in 1973 in English language(s). |
| (PubHealth.info® Document ID: CONT8T 574-06. All rights reserved with PubHealth.info) PIN: 35574 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |